Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Expert Opinion on Biological Therapy
|
June 23, 2020
PanErbB-targeted CAR T-cell immunotherapy of head and neck cancer
Daniel Larcombe-Young, Sophie Papa, John Maher
STAR Protocols
|
May 27, 2022
Generation of human parallel chimeric antigen receptor (pCAR) T cells to achieve synergistic T cell co-stimulation
Daniel Larcombe-Young, Lynsey Whilding, David Marc Davies, et al.
Immunotherapy Advances
|
June 27, 2025
GLUT5 armouring enhances adoptive T-cell therapy anti-tumour activity under glucose-limiting conditions
Robert Page, Olivier Martinez, Daniel Larcombe-Young, et al.
Biology
|
March 27, 2024
Engineering a Dual Specificity γδ T-Cell Receptor for Cancer Immunotherapy
David M Davies, Giuseppe Pugliese, Ana C Parente Pereira, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 15, 2024
Granzyme B-activated IL18 potentiates αβ and γδ CAR T cell immunotherapy in a tumor-dependent manner
Caroline M Hull, Daniel Larcombe-Young, Roberta Mazza, et al.
Clinical and Experimental Immunology
|
May 27, 2026
Optimisation of a parallel CAR for B-cell lymphoma via ITAM attenuation and target specificity validation
Fahima Kausar, Christopher Davis, Daniel Larcombe-Young, et al.
Frontiers in Immunology
|
February 28, 2022
Engineering of an Avidity-Optimized CD19-Specific Parallel Chimeric Antigen Receptor That Delivers Dual CD28 and 4-1BB Co-Stimulation
Leena Halim, Kushal K Das, Daniel Larcombe-Young, et al.
Cell Reports. Medicine
|
May 5, 2021
Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors
Paris Kosti, James W Opzoomer, Karen I Larios-Martinez, et al.
Scientific Reports
|
June 3, 2020
Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug Conjugates (ADCs)
Ricarda M Hoffmann, Silvia Mele, Anthony Cheung, et al.
Cell Reports. Medicine
|
November 20, 2024
Solid tumor immunotherapy using NKG2D-based adaptor CAR T cells
Jana Obajdin, Daniel Larcombe-Young, Maya Glover, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Expert Opinion on Biological Therapy
|
June 23, 2020
PanErbB-targeted CAR T-cell immunotherapy of head and neck cancer
Daniel Larcombe-Young, Sophie Papa, John Maher
STAR Protocols
|
May 27, 2022
Generation of human parallel chimeric antigen receptor (pCAR) T cells to achieve synergistic T cell co-stimulation
Daniel Larcombe-Young, Lynsey Whilding, David Marc Davies, et al.
Immunotherapy Advances
|
June 27, 2025
GLUT5 armouring enhances adoptive T-cell therapy anti-tumour activity under glucose-limiting conditions
Robert Page, Olivier Martinez, Daniel Larcombe-Young, et al.
Biology
|
March 27, 2024
Engineering a Dual Specificity γδ T-Cell Receptor for Cancer Immunotherapy
David M Davies, Giuseppe Pugliese, Ana C Parente Pereira, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 15, 2024
Granzyme B-activated IL18 potentiates αβ and γδ CAR T cell immunotherapy in a tumor-dependent manner
Caroline M Hull, Daniel Larcombe-Young, Roberta Mazza, et al.
Clinical and Experimental Immunology
|
May 27, 2026
Optimisation of a parallel CAR for B-cell lymphoma via ITAM attenuation and target specificity validation
Fahima Kausar, Christopher Davis, Daniel Larcombe-Young, et al.
Frontiers in Immunology
|
February 28, 2022
Engineering of an Avidity-Optimized CD19-Specific Parallel Chimeric Antigen Receptor That Delivers Dual CD28 and 4-1BB Co-Stimulation
Leena Halim, Kushal K Das, Daniel Larcombe-Young, et al.
Cell Reports. Medicine
|
May 5, 2021
Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors
Paris Kosti, James W Opzoomer, Karen I Larios-Martinez, et al.
Scientific Reports
|
June 3, 2020
Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug Conjugates (ADCs)
Ricarda M Hoffmann, Silvia Mele, Anthony Cheung, et al.
Cell Reports. Medicine
|
November 20, 2024
Solid tumor immunotherapy using NKG2D-based adaptor CAR T cells
Jana Obajdin, Daniel Larcombe-Young, Maya Glover, et al.
Page
of 2